Remifentanil versus rocuronium for optimizing video laryngoscopy assisted tracheal intubation in patients undergoing general anaesthesia - a multicentre randomised controlled trial The ROCVIDEO trial

Condition studied

Adult patients undergoing tracheal intubation using video laryngoscopy.

Investigational medicinal product(s)

Eligibility

Primary endpoint

Safety: A composite of one or more intubation or anaesthesia-related adverse events: Early (< 20 min): Cardiac arrest, anaphylaxis, pulmonary aspiration, serious traumatic airway injury, desaturation, major hemodynamic event, new onset bradycardia, sustained new arrhythmia Late (< 24 h): Death, brain damage including stroke, acute myocardial infarction, ICU admission, re-intubation, postoperative respiratory failure, intraoperative awareness, pneumonia, dental injury, sore throat, or hoarsenes, Efficacy: Prevalence of failed first-pass intubation. Defined as failed tracheal tube delivery after the first attempt to introduce the video laryngoscope into the patient’s mouth.